Hypocalcemia Induced by Raloxifene
| Autor: | Thuy D.T. Vu, Suresh Varadarajan, Richard J MacIsaac, George Jerums, Ego Seeman |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Osteoporosis Postmenopausal osteoporosis Toxicology Gastroenterology vitamin D deficiency Internal medicine medicine Humans Mass Screening Pharmacology (medical) Raloxifene Osteoporosis Postmenopausal Mass screening Aged 80 and over Pharmacology Bone Density Conservation Agents Hypocalcemia Raloxifene Hydrochloride business.industry Vitamin D Deficiency medicine.disease Occult Endocrinology Female business medicine.drug |
| Zdroj: | Scopus-Elsevier |
| ISSN: | 1574-8863 |
| DOI: | 10.2174/157488612802715654 |
| Popis: | Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|